Testing Berobenatide for Weight Loss in Overweight Adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a BMI of 30 or higher, OR a BMI of 27–30 with at least one weight-related health condition (high blood pressure, high cholesterol, sleep apnea, heart disease, or type 2 diabetes)
- Your weight has not changed by more than 5% in the past 3 months
- You do not have type 1 diabetes or other forms of diabetes besides type 2
- You do not have a history of pancreatitis (pancreas inflammation)
- You do not have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN-2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new medicine called berobenatide is absorbed into the body in adults who are overweight or have obesity. It aims to find the best way to give the medicine and may help with future weight management.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
This study tests an investigational medicine given once a month to help Chinese adults with overweight or obesity lose weight. It is a placebo-controlled trial, meaning some participants will receive a dummy injection, and the study will compare the effects.
This study tests a once-weekly injection called berobenatide to see if it helps adults with obesity lose weight and improve related health problems like high blood pressure, high cholesterol, or blood sugar issues. It is for people living in Japan.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.